FDA Drug Application (022545) for TEKAMLO by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022545
Product Number001
FormTABLET;ORAL
DosageEQ 150MG BASE;EQ 5MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTEKAMLO
Active IngredientALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Active IngredientCount
List of drugs with Active Ingredient ALISKIREN HEMIFUMARATE5
List of drugs with Active Ingredient AMLODIPINE BESYLATE21


Back to FDA Applications sponsored by NOVARTIS